Eton Pharmaceuticals, Inc. (ETON) shareholders
Close on Nov 17, 2026Market cap $1.82BP/E 163.2Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Opaleye Management, Inc. | 2,672,500 | 10.34% | 13G (passive) amendment | Sep 9, 2024 |
| Opaleye Management Inc. Joint filing with Silverman James (8.54%), Opaleye, L.P. (8.47%) | 2,440,000 | 8.54% | 13G (passive) amendment | Sep 30, 2026 |
| EcoR1 Capital, LLC Joint filing with Oleg Nodelman (7.70%), EcoR1 Capital Fund Qualified, L.P. (7.20%) | 1,981,003 | 7.70% | 13G (passive) amendment | Dec 31, 2024 |
| BlackRock, Inc. | 1,882,410 | 6.90% | 13G (passive) amendment | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ETON | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Opaleye Management Inc. | 2,860,000 | 10.01% | $103.53M | – | 9.38% |
| Nantahala Capital Management, LLC | 2,351,902 | 8.23% | $85.14M | +1,175,951 | 1.41% |
| EcoR1 Capital, LLC | 2,171,938 | 7.60% | $78.62M | – | 3.82% |
| BlackRock, Inc. | 1,895,833 | 6.63% | $68.63M | +178,547 | 0.00% |
| Vanguard Capital Management LLC | 976,570 | 3.42% | $35.35M | −17,519 | 0.00% |
| Morgan Stanley | 767,972 | 2.69% | $27.80M | +290,015 | 0.00% |
| State Street Corp | 701,786 | 2.46% | $25.40M | +171,571 | 0.00% |
| Geode Capital Management, LLC | 652,303 | 2.28% | $23.62M | +74,637 | 0.00% |
| Oberweis Asset Management Inc/ | 501,600 | 1.75% | $18.16M | +62,300 | 0.38% |
| National Philanthropic Trust | 492,112 | 1.72% | $17.81M | – | 0.26% |
| Westside Investment Management, Inc. | 431,160 | 1.51% | $15.61M | −36,755 | 2.05% |
| Pillsbury Lake Capital LLC | 387,157 | 1.35% | $14.02M | +22,203 | 3.83% |
| Nuveen, LLC | 375,707 | 1.31% | $13.60M | +317,757 | 0.00% |
| Bnp Paribas Arbitrage, Snc | 322,466 | 1.13% | $11.67M | +20,358 | 0.00% |
| Woodline Partners LP | 310,879 | 1.09% | $11.25M | +140,180 | 0.03% |
| Thompson Siegel & Walmsley LLC | 297,232 | 1.04% | $10.76M | −108,857 | 0.19% |
| Northern Trust Corp | 255,849 | 0.90% | $9.26M | +18,017 | 0.00% |
| Marshall Wace, Llp | 249,182 | 0.87% | $9.02M | +166,461 | 0.01% |
| Panoramic Capital, LLC | 208,192 | 0.73% | $7.54M | +23,192 | 3.24% |
| Vanguard Portfolio Management LLC | 194,591 | 0.68% | $7.04M | +42,843 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 165 | 21M | 74.0% | 55 / 58 | 36 / 5 | 5M | 1M |
| Q1 2026 | 116 | 18M | 62.2% | 30 / 36 | 32 / 17 | 3M | 1M |
| Q4 2025 | 104 | 16M | 57.4% | 21 / 28 | 37 / 19 | 1M | 3M |
| Q3 2025 | 103 | 19M | 64.9% | 27 / 26 | 28 / 11 | 3M | 1M |
| Q2 2025 | 87 | 17M | 59.7% | 26 / 35 | 19 / 25 | 5M | 2M |
| Q1 2025 | 86 | 15M | 51.1% | 26 / 29 | 22 / 11 | 3M | 2M |
| Q4 2024 | 71 | 14M | 47.7% | 27 / 27 | 11 / 3 | 4M | 1M |
| Q3 2024 | 48 | 10M | 35.0% | 13 / 10 | 9 / 9 | 2M | 1M |
| Q2 2024 | 45 | 10M | 34.5% | 7 / 6 | 16 / 6 | 3M | 0M |
| Q1 2024 | 44 | 8M | 26.9% | 2 / 13 | 13 / 13 | 1M | 0M |
| Q4 2023 | 56 | 8M | 26.8% | 14 / 19 | 9 / 8 | 1M | 1M |
| Q3 2023 | 50 | 7M | 24.1% | 22 / 10 | 5 / 5 | 1M | 1M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
114 funds held ETON in Q2 2026, 60% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of ETON | Value | % of fund | As of |
|---|---|---|---|---|---|
| iShares Russell 2000 ETF | 694,013 | 2.43% | $25.12M | 0.03% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 684,821 | 2.40% | $24.79M | 0.00% | Jun 30, 2026 |
| Oberweis Micro-Cap Fund | 483,900 | 1.69% | $17.52M | 1.08% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 291,898 | 1.02% | $13.55M | 0.04% | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 271,079 | 0.95% | $9.81M | 0.01% | Jun 30, 2026 |
| Nuveen Quant Small Cap Equity Fund | 253,380 | 0.89% | $11.76M | 0.29% | Jul 31, 2026 |
| Fidelity Small Cap Growth Fund | 252,960 | 0.88% | $11.74M | 0.13% | Jul 31, 2026 |
| iShares Russell 2000 Growth ETF | 246,453 | 0.86% | $8.92M | 0.06% | Jun 30, 2026 |
| State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF | 154,434 | 0.54% | $5.59M | 1.30% | Jun 30, 2026 |
| Fidelity Small Cap Growth K6 Fund | 131,980 | 0.46% | $6.13M | 0.13% | Jul 31, 2026 |
| Vanguard Russell 2000 Index Fund | 131,634 | 0.46% | $4.01M | 0.02% | May 31, 2026 |
| Fidelity Extended Market Index Fund | 119,450 | 0.42% | $3.64M | 0.01% | May 31, 2026 |
| Wasatch Micro Cap Fund | 91,924 | 0.32% | $3.33M | 0.49% | Jun 30, 2026 |
| iShares Micro-Cap ETF | 89,743 | 0.31% | $3.25M | 0.21% | Jun 30, 2026 |
| Fidelity SAI Small-Mid Cap Momentum Index Fund | 70,461 | 0.25% | $3.27M | 0.08% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Sean Brynjelsen | President & CEO, Director | 1,029,849 | 3.60% | Aug 20, 2026 |
| Ipek Erdogan-Trinkaus | Chief Commercial Officer | 4,081 | 0.01% | Nov 12, 2026 |
| David Krempa | Chief Business Officer | 43,381 | 0.15% | Oct 6, 2026 |
| Danka Radosavljevic | Chief Operating Officer | 22,473 | 0.08% | Aug 12, 2026 |
| Judith M. Matthews | Chief Financial Officer | – | – | Aug 4, 2026 |
| James R. Gruber | Chief Financial Officer | 213,420 | 0.75% | Jan 14, 2026 |
| Charles J. Casamento | Director | 0 | – | Nov 10, 2026 |
| Paul V. Maier | Director | 73,358 | 0.26% | Aug 31, 2026 |
| Jennifer McKie Adams | Director | 0 | – | Aug 4, 2026 |
| Norbert G. Riedel | Director | 204,645 | 0.72% | Aug 4, 2026 |
| Management Inc. Opaleye | 10% owner | 2,705,000 | 9.46% | Jul 17, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Ipek Erdogan-Trinkaus Chief Commercial Officer | Nov 10, 2026 | Sale | −1,160 | $67.88 | $78.74K | 4,081 |
| Ipek Erdogan-Trinkaus Chief Commercial Officer | Nov 10, 2026 | Sale | −2,340 | $67.18 | $157.20K | 5,241 |
| Ipek Erdogan-Trinkaus Chief Commercial Officer | Nov 10, 2026 | Option exercise | +3,500 | $15.47 | $54.15K | 7,581 |
| Charles J. Casamento Director | Nov 10, 2026 | Sale | −2,903 | $67.87 | $197.03K | 0 |
| Charles J. Casamento Director | Nov 10, 2026 | Sale | −33,956 | $67.11 | $2.28M | 2,903 |
| Charles J. Casamento Director | Nov 10, 2026 | Sale | −22,601 | $66.26 | $1.50M | 36,859 |
| Charles J. Casamento Director | Nov 10, 2026 | Sale | −14,715 | $65.32 | $961.26K | 59,460 |
| Charles J. Casamento Director | Nov 10, 2026 | Sale | −6,380 | $64.33 | $410.42K | 74,175 |
| Charles J. Casamento Director | Nov 10, 2026 | Option exercise | +21,000 | $3.78 | $79.38K | 80,555 |
| Charles J. Casamento Director | Nov 10, 2026 | Option exercise | +19,655 | $8.61 | $169.23K | 59,555 |
| Charles J. Casamento Director | Nov 10, 2026 | Option exercise | +27,400 | $3.58 | $98.09K | 39,900 |
| Charles J. Casamento Director | Nov 10, 2026 | Option exercise | +12,500 | $7.31 | $91.38K | 12,500 |
| David Krempa Chief Business Officer | Oct 6, 2026 | Sale | −4,166 | $55.07 | $229.41K | 43,381 |
| David Krempa Chief Business Officer | Oct 2, 2026 | Option exercise | +10,522 | – | – | 47,547 |
| Paul V. Maier Director | Aug 28, 2026 | Sale | −36,387 | $58.64 | $2.13M | 73,358 |
| Paul V. Maier Director | Aug 28, 2026 | Option exercise | +50,000 | $3.78 | $189.00K | 109,745 |
| Paul V. Maier Director | Aug 28, 2026 | Sale | −128 | $61.77 | $7.91K | 59,745 |
| Paul V. Maier Director | Aug 28, 2026 | Sale | −13,485 | $60.21 | $811.93K | 59,873 |
| Paul V. Maier Director | Aug 28, 2026 | Option exercise | +12,500 | $7.31 | $91.38K | 72,245 |
| Paul V. Maier Director | Aug 28, 2026 | Sale | −36,387 | $58.64 | $2.13M | 73,358 |
| Paul V. Maier Director | Aug 28, 2026 | Sale | −13,485 | $60.21 | $811.93K | 59,873 |
| Paul V. Maier Director | Aug 28, 2026 | Sale | −128 | $61.77 | $7.91K | 59,745 |
| Paul V. Maier Director | Aug 28, 2026 | Option exercise | +50,000 | $3.78 | $189.00K | 109,745 |
| David Krempa Chief Business Officer | Aug 24, 2026 | Sale | −25,000 | $65.07 | $1.63M | 37,025 |
| David Krempa Chief Business Officer | Aug 24, 2026 | Option exercise | +25,000 | $7.31 | $182.75K | 62,025 |
| Sean Brynjelsen President & CEO, Director | Aug 20, 2026 | Sale | −47,307 | $60.17 | $2.85M | 1,004,909 |
| Sean Brynjelsen President & CEO, Director | Aug 20, 2026 | Sale | −36,373 | $61.11 | $2.22M | 968,536 |
| Sean Brynjelsen President & CEO, Director | Aug 20, 2026 | Sale | −7,342 | $62.12 | $456.09K | 961,194 |
| Sean Brynjelsen President & CEO, Director | Aug 19, 2026 | Sale | −8,978 | $62.65 | $562.47K | 1,052,216 |
| Management Inc. Opaleye 10% owner | Jul 14, 2026 | Sale | −15,000 | $37.54 | $563.10K | 2,665,000 |
| Management Inc. Opaleye 10% owner | Jul 14, 2026 | Sale | −13,315 | $37.54 | $499.85K | 40,000 |
| Management Inc. Opaleye 10% owner | Jul 14, 2026 | Sale | −13,315 | $37.54 | $499.85K | 40,000 |
| Management Inc. Opaleye 10% owner | Jul 14, 2026 | Sale | −15,000 | $37.54 | $563.10K | 2,665,000 |
| Sean Brynjelsen President & CEO, Director | Jul 14, 2026 | Option exercise | +200,000 | $1.37 | $274.00K | 1,061,194 |
| Sean Brynjelsen President & CEO, Director | Jul 12, 2026 | Option exercise | +27,500 | – | – | 861,194 |
| David Krempa Chief Business Officer | Jul 12, 2026 | Option exercise | +10,000 | – | – | 37,025 |
| Management Inc. Opaleye 10% owner | Jul 7, 2026 | Sale | −6,685 | $38.37 | $256.50K | 53,315 |
| Management Inc. Opaleye 10% owner | Jul 7, 2026 | Sale | −20,000 | $38.37 | $767.40K | 2,680,000 |
| Management Inc. Opaleye 10% owner | Jul 6, 2026 | Sale | −10,000 | $38.00 | $380.00K | 2,700,000 |
| Management Inc. Opaleye 10% owner | Jul 2, 2026 | Sale | −65,000 | $37.39 | $2.43M | 2,710,000 |
| Management Inc. Opaleye 10% owner | Jul 2, 2026 | Sale | −25,000 | $37.39 | $934.75K | 60,000 |
| Jennifer McKie Adams Director | Jun 17, 2026 | Sale | −50,000 | $32.48 | $1.62M | 0 |
| Jennifer McKie Adams Director | Jun 17, 2026 | Option exercise | +50,000 | $3.78 | $189.00K | 50,000 |
| Sean Brynjelsen President & CEO, Director | May 28, 2026 | Sale | −119,852 | $31.88 | $3.82M | 833,842 |
| Sean Brynjelsen President & CEO, Director | May 28, 2026 | Sale | −148 | $32.67 | $4.84K | 833,694 |
| David Krempa Chief Business Officer | May 27, 2026 | Sale | −19,679 | $31.47 | $619.30K | 25,249 |
| David Krempa Chief Business Officer | May 27, 2026 | Option exercise | +7,203 | $3.58 | $25.79K | 44,928 |
| David Krempa Chief Business Officer | May 27, 2026 | Option exercise | +12,476 | $1.37 | $17.09K | 37,725 |
| David Krempa Chief Business Officer | May 26, 2026 | Sale | −37,524 | $31.49 | $1.18M | 25,249 |
| David Krempa Chief Business Officer | May 26, 2026 | Option exercise | +12,524 | $1.37 | $17.16K | 62,773 |
| David Krempa Chief Business Officer | May 26, 2026 | Option exercise | +25,000 | $1.38 | $34.50K | 50,249 |
| David Krempa Chief Business Officer | May 22, 2026 | Option exercise | +30,591 | $3.58 | $109.52K | 68,046 |
| David Krempa Chief Business Officer | May 22, 2026 | Sale | −32,963 | $33.22 | $1.10M | 35,083 |
| David Krempa Chief Business Officer | May 22, 2026 | Sale | −519 | $35.00 | $18.17K | 25,249 |
| David Krempa Chief Business Officer | May 22, 2026 | Sale | −9,315 | $33.88 | $315.59K | 25,768 |
| Norbert G. Riedel Director | Apr 21, 2026 | Option exercise | +12,500 | $7.31 | $91.38K | 47,500 |
| Norbert G. Riedel Director | Apr 21, 2026 | Option exercise | +19,655 | $8.61 | $169.23K | 67,155 |
| Norbert G. Riedel Director | Feb 3, 2026 | Option exercise | +30,000 | $4.42 | $132.60K | 35,000 |
| James R. Gruber Chief Financial Officer | Jan 14, 2026 | Tax withholding | −2,293 | $15.47 | $35.47K | 213,420 |
| David Krempa Chief Business Officer | Jan 14, 2026 | Tax withholding | −1,942 | $15.62 | $30.33K | 630,238 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Eton Pharmaceuticals's stock actually held short. Settlement fails (shares not delivered on time) peaked at 816 shares on Aug 24, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Charles J. Casamento Director | Nov 10, 2026 | 80,555 | $5.34M | Nov 10, 2026 | grant |
| Ipek Erdogan-Trinkaus Officer | Nov 10, 2026 | 3,500 | $235.94K | Nov 10, 2026 | GRANT |
| David Krempa Officer | Oct 6, 2026 | 4,166 | $229.41K | Oct 6, 2026 | RSU Vest |
| Paul V. Maier Director | Aug 28, 2026 | 50,000 | $2.95M | Aug 28, 2026 | stock options |
| David Krempa Officer | Aug 24, 2026 | 25,000 | $1.63M | Aug 24, 2026 | Stock Option Exercise |
| Sean Brynjelsen Officer, Director | Aug 20, 2026 | 100,000 | $6.34M | Aug 19, 2026 | founder shares |
| Sean Brynjelsen Director, 10% Stockholder | Aug 19, 2026 | 100,000 | $6.34M | Aug 19, 2026 | Founder Shares |
| James R. Gruber Officer | Jun 26, 2026 | 251,818 | $8.99M | Jun 26, 2026 | Stock Option Exercies |
| James R. Gruber Officer | Jun 25, 2026 | 25,000 | $875.25K | Jun 25, 2026 | Stock Option Exercise |
| James R. Gruber Officer | Jun 23, 2026 | 25,000 | $830.87K | Jun 23, 2026 | Stock Option Exercise |
| Jennifer McKie Adams Director | Jun 17, 2026 | 50,000 | $1.62M | Jun 17, 2026 | Stock Options |
| James R. Gruber Officer | Jun 2, 2026 | 3,117 | $84.16K | Jun 2, 2026 | RSU |
| Sean Brynjelsen Director | May 28, 2026 | 120,000 | $3.89M | May 28, 2026 | Founder Shares |
| David Krempa Officer | May 22, 2026 | 100,000 | $3.50M | May 22, 2026 | RSU |
| David Krempa Officer | Jan 14, 2026 | 1,942 | $30.33K | Jan 14, 2026 | Grant |
See a number that looks wrong?